Rapid Micro Biosystems (RPID) EBT (2020 - 2026)
Rapid Micro Biosystems (RPID) reported EBT of -$14.3 million for Q1 2026, down 26.75% on a YoY basis from -$19.5 million in Q1 2025, and down 14.29% sequentially from -$12.5 million in Q4 2025.
Rapid Micro Biosystems (RPID) EBT (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of EBT data on file, last reported at -$14.3 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 26.75% year-over-year to -$14.3 million; the trailing twelve-month figure through Mar 2026 stood at -$50.1 million (down 11.81% YoY), and the FY2025 full-year result was -$47.1 million, changed 0.46% from the prior year.
- EBT declined to -$14.3 million in Q1 2026, from -$12.5 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$9.7 million in Q4 2024 to a low of -$16.4 million in Q4 2022.
- A 5-year average of -$13.1 million and a median of -$13.3 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT jumped 34.59% in 2022 and dropped 29.02% in 2025, its largest moves.
- Tracing RPID's EBT over 5 years: stood at -$16.4 million in 2022, then surged by 32.09% to -$11.2 million in 2023, then climbed by 13.34% to -$9.7 million in 2024, then retreated by 29.02% to -$12.5 million in 2025, then decreased by 14.29% to -$14.3 million in 2026.
- Business Quant data shows RPID's EBT at -$14.3 million in Q1 2026, -$12.5 million in Q4 2025, and -$11.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | -14.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.27 Mn |
| Dec 31, 2025 | -12.48 Mn |
| Sep 30, 2025 | -11.50 Mn |
| Jun 30, 2025 | -11.85 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | -9.68 Mn |
| Sep 30, 2024 | -11.31 Mn |
| Jun 30, 2024 | -12.56 Mn |
| Mar 31, 2024 | -13.32 Mn |
| Dec 31, 2023 | -11.16 Mn |
| Sep 30, 2023 | -13.38 Mn |
| Jun 30, 2023 | -14.01 Mn |
| Mar 31, 2023 | -13.88 Mn |
| Dec 31, 2022 | -16.44 Mn |
| Sep 30, 2022 | -16.33 Mn |
| Jun 30, 2022 | -13.70 Mn |
| Mar 31, 2022 | -14.91 Mn |
| Dec 31, 2021 | -14.57 Mn |
| Sep 30, 2021 | -24.97 Mn |
| Jun 30, 2021 | -11.81 Mn |